Multi-omics synergy in oncology: Unraveling the complex interplay of radiomic, genoproteomic, and pathological data
Review article|更新时间:2026-06-03
|
Multi-omics synergy in oncology: Unraveling the complex interplay of radiomic, genoproteomic, and pathological data
Multi-omics synergy in oncology: Unraveling the complex interplay of radiomic, genoproteomic, and pathological data
智能肿瘤学2025年1卷第1期 页码:17-30
作者机构:
1. Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences,Beijing,China,100190
2. Beijing Key Laboratory of Molecular Imaging,Beijing,China,100190
3. School of Life Science and Technology, Xidian University,Shaanxi,Xi’an,China,710126
4. School of Public Health, Anhui Medical University,Anhui,Hefei,China,230032
5. Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University,Beijing,China,100191
6. School of Engineering Medicine, Beihang University,Beijing,China,100191
7. Key Laboratory of Big Data-Based Precision Medicine, Ministry of Industry and Information Technology, Beihang University,Beijing,China,100191
8. Engineering Research Center of Molecular and Neuro Imaging of Ministry of Education, School of Life Science and Technology, Xidian University,Shaanxi,Xi’an,China,710126
Yang Luo, Yilin Li, Mengjie Fang, 等. Multi-omics synergy in oncology: Unraveling the complex interplay of radiomic, genoproteomic, and pathological data[J]. 智能肿瘤学, 2025,1(1):17-30.
Yang Luo, Yilin Li, Mengjie Fang, et al. Multi-omics synergy in oncology: Unraveling the complex interplay of radiomic, genoproteomic, and pathological data[J]. Intelligent Oncology, 2025, 1(1): 17-30.
Yang Luo, Yilin Li, Mengjie Fang, 等. Multi-omics synergy in oncology: Unraveling the complex interplay of radiomic, genoproteomic, and pathological data[J]. 智能肿瘤学, 2025,1(1):17-30.DOI: 10.1016/j.intonc.2024.10.003.
Yang Luo, Yilin Li, Mengjie Fang, et al. Multi-omics synergy in oncology: Unraveling the complex interplay of radiomic, genoproteomic, and pathological data[J]. Intelligent Oncology, 2025, 1(1): 17-30.DOI: 10.1016/j.intonc.2024.10.003.
Multi-omics synergy in oncology: Unraveling the complex interplay of radiomic, genoproteomic, and pathological data
The advent of multi-omics approaches has revolutionized the field of oncology by enabling a comprehensive understanding of cancer biology through the integration of diverse biological data. This review aims to explore the synergy between three key omics domains: radiomics
genoproteomics
and pathomics. Radiomics involves extracting high-dimensional data from medical images
providing valuable insights into tumor heterogeneity and treatment response. Genoproteomics
encompassing both genomic and proteomic analyses
delves into the molecular mechanisms driving cancer progression and therapeutic resistance. Pathomics leverages advanced digital pathology techniques to quantitatively analyze tissue architecture and cellular morphology. We provide an in-depth overview of the methodologies and tools employed in each omics field
highlighting their specific applications in oncology
including cancer diagnosis
biomarker discovery
and prediction of treatment outcomes. Furthermore
we discuss the integration of multi-omics data
addressing the challenges and innovative solutions for harmonizing these complex datasets. Through an examination of recent advancements and case studies
we underscore the critical role of multi-omics in advancing our understanding of cancer and paving the way for more effective and personalized therapeutic strategies.
Abstract
The advent of multi-omics approaches has revolutionized the field of oncology by enabling a comprehensive understanding of cancer biology through the integration of diverse biological data. This review aims to explore the synergy between three key omics domains: radiomics
genoproteomics
and pathomics. Radiomics involves extracting high-dimensional data from medical images
providing valuable insights into tumor heterogeneity and treatment response. Genoproteomics
encompassing both genomic and proteomic analyses
delves into the molecular mechanisms driving cancer progression and therapeutic resistance. Pathomics leverages advanced digital pathology techniques to quantitatively analyze tissue architecture and cellular morphology. We provide an in-depth overview of the methodologies and tools employed in each omics field
highlighting their specific applications in oncology
including cancer diagnosis
biomarker discovery
and prediction of treatment outcomes. Furthermore
we discuss the integration of multi-omics data
addressing the challenges and innovative solutions for harmonizing these complex datasets. Through an examination of recent advancements and case studies
we underscore the critical role of multi-omics in advancing our understanding of cancer and paving the way for more effective and personalized therapeutic strategies.